RALEIGH, N.C., Feb. 11, 2014 /PRNewswire/ -- PRA, a leading clinical research organization, today announced it has been named the 2014 "International Clinical Company of the Year" at the competition's finals ceremony recently held in London. In addition, several PRA employees received individual honors. This international award comes on the heels of PRA being named the "2013 U.S. Clinical Company of the Year" for the second consecutive year this past November.
Organized by PharmaTimes, the event named PRA "International Clinical Company of the Year" based on the total points earned by its employees' performances in individual competitions. Eight PRA employees across six categories were invited to attend the in-person finals competition. They competed in a rigorous three-phase process, consisting of an ICH-GCP quiz, a four-part essay question designed to test the applicant in his or her own discipline and a live final with real-life scenarios.
"The awards are a great reflection of our employees' focus on quality and their passion for working through the drug development process to help bring safe and effective treatments to market that improve the quality of life for patients," said PRA Executive Vice President of Product Registration – Europe, Asia Pacific, and Africa, Sean Leech. "Being named both International and U.S. Clinical Company of the Year is a global achievement that speaks to the level of commitment and dedication to our employees and customers."
PRA employees earning this year's awards include:
- First Place Award – Clinical Research Associate Category, Vicky Hawkins (Clinical Research Associate)
- Silver Award – Team Category, Alison Edwards (Project Manager), Angharad Smith (Clinical Team Manager), Charlotte Craggs (Clinical Research Associate) and Clare Jeffrey (In-House Clinical Research Associate)
- Bronze Award – Clinical Team Leader Category, Emma Lewis (Director of Clinical Operations)
One of the world's largest CROs, PRA is transforming clinical trials through its people, innovation and operational transparency. PRA's 10,000+ employees operate in more than 80 countries, delivering a broad spectrum of full-service and Embedded clinical trial solutions that meet the demands of a diverse marketplace.
Over the last 30+ years, PRA has established a reputation for specialized expertise and success in a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. PRA's forward-thinking approach to clinical research innovation, customized recruitment strategies and technological advances continues to make a difference to healthcare patients around the world.